Imbalances in lipoprotein metabolism have been associated with vaso-occlusive events in individuals with sickle cell disease (SCD). The research, led by Dr. Eric Soupene in Dr. Frans Kuypers' laboratory, identified high-density lipoprotein (HDL) metabolites in SCD plasma that enhance inflammation and diminish the effectiveness of current therapies. This study has been published in Experimental Biology and Medicine.
All news from Immuno Haematology & Blood Transfusion
Blood plasma infusion, Alzheimer's disease could be safe, feasible and improve their functional ability and capacity to perform daily tasks, according to a study led by the Stanford University School of Medicine Medicine